These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3674962)

  • 21. PMN migration measured by bottom filter counts in modified Boyden chambers. Chemokinetic deactivation and vinblastine inhibition of chemotaxis.
    Bandman U; Norberg B; Eriksson S
    Haematologia (Budap); 1986; 19(1):13-9. PubMed ID: 3721320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis.
    Walsdorfer U; Christophers E; Schröder JM
    Br J Dermatol; 1983 Apr; 108(4):451-6. PubMed ID: 6838769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A; Labro MT; Hakim J
    Biochem Pharmacol; 1982 Oct; 31(19):3071-6. PubMed ID: 6756410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients.
    Griffin E; Håkansson L; Formgren H; Jörgensen K; Venge P
    Allergy; 1991 May; 46(4):255-65. PubMed ID: 1897687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pustulosis palmaris et plantaris and psoriasis--study on chemoattracting properties of the sera].
    Yamaji K
    Nihon Hifuka Gakkai Zasshi; 1986 May; 96(6):595-9. PubMed ID: 2943919
    [No Abstract]   [Full Text] [Related]  

  • 29. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
    Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM
    J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestatin.
    Leid RW; Grant RF; Suquet CM
    Parasite Immunol; 1987 Mar; 9(2):195-204. PubMed ID: 3574975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of chemotactic factors in serum and wound fluid by dextranomer.
    Oredsson SU; Gottrup F; Beckmann A; Hohn DC
    Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?
    Langner A; Chorzelski TP; Fraczykowska M; Jabłońska S; Symańczyk
    Arch Dermatol Res; 1983; 275(4):226-8. PubMed ID: 6625647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New method for the measurement of eosinophil migration.
    Håkansson L; Westerlund D; Venge P
    J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
    Valerius NH
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial characterization and identification of chemokinetic factors in serum.
    Håkansson L; Venge P
    Scand J Immunol; 1983 Dec; 18(6):531-7. PubMed ID: 6198716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.